tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,044 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is 2.44, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 61.59, while Halozyme Therapeutics’s (HALO) share price is $67.27, making it a Buy.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 58.93, while Halozyme Therapeutics’s (HALO) share price is $67.27, making it a Buy.

Halozyme (HALO) Pivot Points

Aug 19, 2025, 03:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
63.05
63.73
64.64
65.32
66.22
66.90
67.81
Fibonacci
63.73
64.34
64.71
65.32
65.92
66.30
66.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Aug 19, 2025, 03:53 AM
Period
Simple
Exponential
MA5
64.97Buy
65.23Buy
MA10
63.30Buy
63.66Buy
MA20
60.89Buy
61.59Buy
MA50
57.07Buy
58.93Buy
MA100
57.95Buy
57.97Buy
MA200
56.12Buy
56.82Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 63.66, while Halozyme Therapeutics’s (HALO) share price is $67.27, making it a Buy.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 57.97, while Halozyme Therapeutics’s (HALO) share price is $67.27, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $67.27 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 57.07, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $67.27 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 57.95, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $67.27 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 56.12, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Aug 19, 2025, 03:53 AM
Name
Value
Implied Action
RSI (14)
80.45
Sell
STOCH (9,6)
96.08
Sell
STOCHRSI (14)
96.57
Sell
MACD (12,26)
2.44
Sell
ADX (14)
35.27
Neutral
Williams %R
-1.29
Sell
CCI (14)
160.74
Sell
ATR (14)
1.64
-
Ultimate Oscillator
67.02
Neutral
ROC
16.53
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 80.45, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 35.27, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is 160.74, creating a Sell signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 16.53, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Buy.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 80.45, which suggests HALO is a Sell.
      What is HALO’s MACD?
      HALO’s MACD is 2.44, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 64.97, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 60.89, which suggests HALO is a Buy.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 57.07, which suggests HALO is a Buy.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 56.12, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -1.29, which suggests HALO is a Sell.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is 160.74, which suggests HALO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis